PMID: 8963728May 1, 1996Paper

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

Arteriosclerosis, Thrombosis, and Vascular Biology
W J MackH N Hodis

Abstract

Accumulating evidence suggests that triglyceride-rich lipoproteins contribute to coronary artery disease. Using data from the Monitored Atherosclerosis Regression Study, an angiographic trial of middle-aged men and women randomized to lovastatin or placebo, we investigated relationships between lipoprotein subclasses and progression of coronary artery atherosclerosis. Coronary artery lesion progression was determined by quantitative coronary angiography in low-grade ( < 50% diameter stenosis), high-grade ( > or = 50% diameter stenosis), and all coronary artery lesions in 220 baseline/2-year angiogram pairs. Analytical ultracentrifugation was used to measure lipoprotein masses that were statistically evaluated for treatment group differences and relationships to progression of coronary artery atherosclerosis. All low density lipoprotein (LDL), intermediate density lipoprotein (IDL), and very low density lipoprotein (VLDL) masses were significantly lowered and all high density lipoprotein (HDL) masses were significantly raised with lovastatin therapy. The mass of smallest LDL (Svedberg flotation rate [Sf] 0 to 3), IDL (Sf 12 to 20), all VLDL subclasses (Sf 20 to 60, Sf 60 to 100, and Sf 100 to 400), and peak LDL flotation rate we...Continue Reading

Associated Clinical Trials

References

Aug 8, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
Dec 1, 1987·Controlled Clinical Trials·D H BlankenhornR H Selzer
Aug 1, 1995·Current Opinion in Lipidology·H N Hodis, W J Mack
Jun 1, 1995·The New England Journal of Medicine·R J Havel, E Rapaport
Nov 15, 1993·Annals of Internal Medicine·D H BlankenhornUNKNOWN MARS Research Group

❮ Previous
Next ❯

Citations

Jun 16, 2006·Cardiovascular Drugs and Therapy·Manfredi Rizzo, Kaspar Berneis
Aug 19, 2008·Current Atherosclerosis Reports·H Robert Superko, Radhika R Gadesam
Jul 27, 2001·The American Journal of Cardiology·J M McKenneyM L Watkins
Dec 7, 2002·The American Journal of Cardiology·Robert S Rosenson
Jul 1, 1997·The American Journal of Cardiology·H R SuperkoC DiRicco
Mar 11, 2000·Disease-a-month : DM·P R Liebson, E A Amsterdam
Jun 8, 2001·Atherosclerosis·T ShojiY Nishizawa
Sep 18, 1998·Diabetes Research and Clinical Practice·G Steiner
Mar 28, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ji ZhouRichard C Austin
Nov 5, 2003·Current Opinion in Cardiology·Antonios M Xydakis, Christie M Ballantyne
Sep 18, 1998·Current Opinion in Lipidology·A Zambon, J E Hokanson
Feb 27, 2001·Current Opinion in Nephrology and Hypertension·C Wanner, T Quaschning
Apr 17, 2008·Cardiology in Review·Joshua RemickArthur Schwartzbard
Nov 6, 2002·Progress in Cardiovascular Nursing·H Robert SuperkoBrenda Garrett
Aug 22, 2012·Annals of Nutrition & Metabolism·Hiroya HidakaTakayuki Honda
Dec 2, 2010·Lipids in Health and Disease·Harold BaysAndrew M Tershakovec
May 12, 2007·The Review of Diabetic Studies : RDS·Riikka LautamäkiTapani Rönnemaa
Aug 12, 2008·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Genovefa D KolovouDennis V Cokkinos
Oct 16, 2007·Journal of Nutritional Science and Vitaminology·Hang GuoFumiki Morimatsu
Nov 14, 2015·Current Medical Research and Opinion·Laurence S Sperling, John R Nelson
Jan 14, 1999·Critical Reviews in Clinical Laboratory Sciences·T C Ooi, D S Ooi
May 26, 2004·Endocrinology and Metabolism Clinics of North America·Ronald M Krauss, Patty W Siri
Nov 13, 2004·Preventive Cardiology·John M MorganDavid M Capuzzi
Dec 28, 2016·Journal of Atherosclerosis and Thrombosis·Daisuke ManitaYuji Hirowatari

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.